Lawrence Traylor

Associate
ltraylor@cooley.com
Full contact info

About Lawrence

Lawrence represents high-growth companies and investment banks on a broad range of capital markets and corporate transactions – including initial public offerings and other public and private equity offerings, as well as high-yield, investment-grade and convertible debt issuances and acquisition financing. Lawrence also regularly advises clients on general corporate matters, including Securities and Exchange Commission reporting and corporate governance.

View full bio

Experience

LegalZoom Announces Upsized $161 Million Follow-on Public Offering

LegalZoom Announces Upsized $161 Million Follow-on Public Offering

September 7, 2023

Cooley advised LegalZoom, a leading online platform for business formation, on its upsized follow-on public offering at $161 million.

Read more

Related contacts

C. Thomas Hopkins
Partner, Los Angeles Santa Monica
Jodie Bourdet
Partner, San Francisco
Logan Tiari
Partner, Los Angeles Downtown
Lawrence Traylor
Associate, Los Angeles Santa Monica
Peter A. Haddad
Associate, San Diego
Rebecca Siegel
Associate, San Francisco
Amy Saldamando
Paralegal Specialist, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Natasha Kaye
Partner, London
Calvin Lee
Associate, New York
Calvin Lee
Associate, New York
Karen Tsai
Special Counsel, Washington, DC
Travis LeBlanc
Partner, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Allison Kutner
Associate, New York
Barbara Mirza
Partner, Los Angeles Santa Monica
Steve Flores
Partner, Chicago
Austin Holt
Partner, Los Angeles Santa Monica
Ellie Guadiana
Partner, Los Angeles Santa Monica
Christopher Hutter
Partner, Reston
Charlie Kim
Partner, San Diego
Francis Wheeler
Partner, Colorado

Related Practices & Industries

Capital Markets
Public Companies
Technology
Tax
CFIUS
Cyber/Data/Privacy
Compensation and Benefits
Debt Finance
Intellectual Property
Corporate Governance and Shareholder Engagement

ACELYRIN Announces Pricing of Upsized Initial Public Offering

ACELYRIN Announces Pricing of Upsized Initial Public Offering

May 15, 2023

Cooley advised Acelyrin, INC., a late-stage biopharmaceutical company, in its $621 million initial public offering, the second-largest biotechnology IPO and largest clinical-stage biotechnology IPO ever.

Read more

Related contacts

Chadwick Mills
Partner, San Francisco
Charlie Kim
Partner, San Diego
Anitha Anne
Associate, San Francisco
Barbara Mirza
Partner, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Joshua Mates
Partner, San Francisco
Phil Mitchell
Partner, New York
Brad Goldberg
Partner, New York
Peter Adams
Partner, San Diego
Lauren Creel
Partner, Palo Alto
Koji Fukumura
Partner, San Diego
Patrick Gibbs
Partner, Palo Alto
David Peinsipp
Partner, San Francisco
Barbara Borden
Partner, San Diego
David Navetta
Partner, Colorado
Patrick Van Eecke
Partner, Brussels
Shannon Eagan
Partner in Charge – Palo Alto, Palo Alto
Darren DeStefano
Partner, Reston
Francis Wheeler
Partner, Colorado
Thomas Welk
Senior Counsel, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Brett White
Of Counsel, Palo Alto
Dani Nazemian
Special Counsel, San Diego
Jennifer Shanley
Special Counsel, New York
Jacquelyn Burke
Special Counsel, Boston
Karen Tsai
Special Counsel, Washington, DC
Miriam Petrillo
Partner, Chicago
Andrew Nelms
Associate, San Francisco
David D. Kim
Associate, San Francisco
Lawrence Traylor
Associate, Los Angeles Santa Monica
Dionne A. Thomas
Associate, San Diego
Nathaniel Hearn Jr.
Associate, Chicago
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Eileen Leman
Associate, Los Angeles Downtown
Kelly McCormick
Associate, San Francisco
Mor Agam
Associate, New York
Allison Kutner
Associate, New York
Madison (JJ) Meng
Associate, San Francisco
Rebecca Siegel
Associate, San Francisco
Rachel F. Katz
Associate, New York
Mari Dugas
Associate, Washington, DC
Megan Drill
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Kristin R. Marshall
Associate, Washington, DC
John T. Stellini
Associate, Palo Alto
Luke X. Blackett
Associate, San Francisco

Related Practices & Industries

Life Sciences
Healthcare
Life Sciences and Healthcare Regulatory
Medtech
Capital Markets
Public Companies
Public Company Advisory Team
Compensation and Benefits
Labor and Employment
Tax
Cyber/Data/Privacy
Securities Litigation + Enforcement
Commercial Litigation
Shareholder Activism
Insurance
Export Controls and Economic Sanctions

Arcutis Biotherapeutics – $172.5 Million Follow-on Offering

Arcutis Biotherapeutics – $172.5 Million Follow-on Offering

August 24, 2022

Cooley advised the underwriters in Arcutis Biotherapeutics’ $172.5 million follow-on offering of 8,625,000 shares of common stock at a public offering price of $20.00 per share. Arcutis is a biopharmaceutical company developing and commercializing innovative treatments for immuno-dermatological diseases. Partners Denny Won, Kristin VanderPas, Charlie Kim and Dave Peinsipp led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
David Peinsipp
Partner, San Francisco
Christine Turner
Associate, Colorado
Madison (JJ) Meng
Associate, San Francisco
Mike Lam
Associate, Los Angeles Santa Monica
Lawrence Traylor
Associate, Los Angeles Santa Monica
Kate Walther
Paralegal Specialist, San Diego

Related Practices & Industries

Capital Markets
Life Sciences
Healthcare

Admissions & credentials

California